Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This second section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery. The first section on definitions and diagnosis includes the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The third section on special situations in Crohn's disease includes postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy for Crohn's disease.

Original publication




Journal article



Publication Date



55 Suppl 1


i16 - i35


Adrenal Cortex Hormones, Aminosalicylic Acids, Anti-Bacterial Agents, Antibodies, Monoclonal, Clinical Trials as Topic, Crohn Disease, Drug Resistance, Evidence-Based Medicine, Gastrointestinal Agents, Humans, Immunosuppressive Agents, Infliximab, Methotrexate, Patient Selection, Purines, Remission Induction, Secondary Prevention